Adicet Bio, Inc. (ACET)
NASDAQ: ACET · Real-Time Price · USD
6.35
-2.67 (-29.60%)
At close: Sep 28, 2026, 4:00 PM EDT
6.37
+0.02 (0.31%)
After-hours: Sep 28, 2026, 4:37 PM EDT
Adicet Bio Market Cap
Adicet Bio has a market cap or net worth of $68.35 million as of September 28, 2026. Its market cap has decreased by -11.26% in one year.
Market Cap
68.35M
Enterprise Value
-36.98M
1-Year Change
-11.26%
Ranking
Category
Stock Price
$6.35
ChartMarket Cap Chart
Since September 16, 2020, Adicet Bio's market cap has decreased from $301.68M to $68.35M, a decrease of -77.34%. That is a compound annual growth rate of -21.81%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 28, 2026 | 68.35M | -19.67% |
| Dec 31, 2025 | 85.10M | -2.63% |
| Dec 31, 2024 | 87.39M | 7.13% |
| Dec 29, 2023 | 81.58M | -78.70% |
| Dec 30, 2022 | 383.09M | -44.04% |
| Dec 31, 2021 | 684.61M | 148.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Polaryx Therapeutics | 104.18M |
| Tenax Therapeutics | 103.68M |
| Cellectis | 103.39M |
| ProMIS Neurosciences | 101.07M |
| PMV Pharmaceuticals | 100.43M |
| Nutriband | 97.25M |
| Anixa Biosciences | 96.64M |
| Cardiff Oncology | 96.47M |